Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Neuropathol Appl Neurobiol. 2013 Jun;39(4):10.1111/j.1365-2990.2012.01289.x. doi: 10.1111/j.1365-2990.2012.01289.x

Table 1.

Summary of mRNA expression measured by microarray expression profiling

Gene Probe sets
n
Probe sets
dysregulated
n
Fold-change
DM vs. N
Fold-change
DM1 vs. DM2
RYR1 1 0 NS NS
CACNA1S 1 0 NS NS
ATP2A1 3 2 (1.47–1.85)a 1.66b NS
ATP2A2 4 2 (1.47–2.04) 1.76 (1.57–1.68) 1.63
CASQ1 1 1 1.81 NS
CASQ2 1 1 2 NS
TRDN 3 3 (2.09–2.86) 2.55 1.79
JPH1 2 2 (1.67–1.88) 1.78 1.93
PPP3CA 9 3 (1.63–6.01) 3.15 NS
NFATC3 4 0 NS NS
a

Range;

b

Average;

NS, not significant for fold-change values <1.2.